Can-Fite Reports 2022 Financial Results & Provides Clinical Update
Go back to Can-Fite Reports 2022 Financial Results & Provides Clinical Update| CAN-FITE BIOPHARMA LTD. (NYSE: CANF) | Delayed: 3.33 -0.02 (0.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.35 | 52 Week High | $3.89 | |||
| Open | $3.35 | 52 Week Low | $1.85 | |||
| Day High | $3.48 | P/E | N/A | |||
| Day Low | $3.33 | EPS | $0.00 | |||
| Volume | 25,625 | |||||
| CAN-FITE BIOPHARMA LTD. (NYSE: CANF) | Delayed: 3.33 -0.02 (0.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.35 | 52 Week High | $3.89 | |||
| Open | $3.35 | 52 Week Low | $1.85 | |||
| Day High | $3.48 | P/E | N/A | |||
| Day Low | $3.33 | EPS | $0.00 | |||
| Volume | 25,625 | |||||

